The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

We consecutively enrolled patients presenting with breast space-occupying lesions at our hospital. Medical imaging data from simultaneously acquired ultrafast DCE-MRI, time-dependent diffusion MRI (TDD-MRI), magnetic resonance elastography (MRE), andvirtual magnetic resonance elastography(vMRE), along with clinical and pathological data, were collected. The study aims to evaluate and explore the clinical application value of these multimodal imaging techniques in the precision diagnosis, treatment, and prognosis of breast cancer. The findings are intended to provide a robust imaging basis for formulating and adjusting more precise, individualized treatment plans and prognostic assessments for patients. Ultimately, this research seeks to improve patient quality of life, optimize the allocation of medical resources, and advance the development of precision medicine.

Key facts

Study ID

NCT07608081

Run by

Yunnan Cancer Hospital

People needed

1000

Starts

2025-10-01

Expected to finish

2027-10-01

Last updated by the study team

2026-05-27

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years old
• Female patients with BI-RADS class 4 or above breast lesions detected by mammography or ultrasound
• Perform breast new technology MRI examination (ultra fast DCE-MRI、OGSE 、MRE、vMRE)within one week before biopsy or surgery

You may not qualify if…

• Previously received breast radiotherapy, chemotherapy, surgery, or targeted therapy
• Unable to cooperate in completing MRI examination
• The image data contains serious artifacts (such as motion artifacts and metal artifacts), making it impossible to measure parameters
• The lesion cannot be clearly identified and outlined on the image
• Pregnant and lactating women
• Combined with severe liver, liver, and kidney diseases, coagulation dysfunction, or other malignant tumors

Where it is running

• Yunnan Cancer Hospital — Kunming, Yunnan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.